FIELD: medicine.
SUBSTANCE: declared invention refers to medicine and pharmaceutics and represents a composition with a fixed combination of doses containing as active ingredients only ibuprofen, drotaverine or their pharmaceutically acceptable salts and one or more pharmaceutically acceptable excipients.
EFFECT: disclosed composition has high stability, wherein the drotaverine and ibuprofen included do not react with each other, wherein the disclosed composition does not contain an unacceptably high level of valardine.
1 cl, 4 tbl, 4 ex
| Title |
Year |
Author |
Number |
| TABLETS CONTAINING TOLFENAMIC ACID OR ITS ACCEPTABLE SALT AND DISTINGUISHED BY RAPID RELEASE OF ACTIVE INGREDIENT |
1996 |
- Knud Ehrik Gebkhar-Khansen
- Karen B'Ernsdottir
- Lars Khedevang Kristensen
- Seren Bol'S Pedersen
|
RU2166939C2 |
| SOLID FORMULATIONS OF OSPEMIFENE |
2005 |
- Lekhtola Veli-Matti
- Khalonen Kajya
|
RU2675624C2 |
| SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING INTEGRASE INHIBITOR |
2010 |
- Madzhur Madzhid
- Li Fen
- Ma Dechen
- Sottkhivirat Suttkhilug
|
RU2602865C2 |
| ANTI-TUBERCULOSIS STABLE PHARMACEUTICAL COMPOSITION IN FORM OF DISPERSIBLE TABLET CONTAINING GRANULATED ISONIAZID AND GRANULATED RIFAPENTINE, AND METHOD FOR PREPARING IT |
2014 |
- Dilip Pradzhapati
- Kum Prasad
- Pravin Kkhullar
- Ramesh Kumar
- Shakti Kumar
|
RU2694056C2 |
| SOLID PREPARATIVE FORMS OF OSPEMIFENE |
2005 |
- Lekhtola Veli-Matti
- Khalonen Kajja
|
RU2423113C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRINE, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE |
2016 |
- Panmai, Santipharp
- Tatavarti, Aditya
- Farrington, Andrew, M.
- Biyyala, Varsha
- Allain, Leonardo, R.
- Nefliu, Marcela
- Klinzing, Gerard, R.
- Ren, Jie
- Lamm, Matthew
|
RU2736941C2 |
| ANTI-TUBERCULOSIS STABLE PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET COMPRISING GRANULES OF ISONIAZID AND GRANULES OF RIFAPENTINE AND ITS PROCESS OF PREPARATION |
2014 |
- Dilip Pradzhapati
- Kum Prasad
- Pravin Kkhullar
- Ramesh Kumar
- Shakti Kumar
|
RU2682178C2 |
| PHARMACEUTICAL COMPOSITIONS WITH CDC7 INHIBITOR |
2019 |
|
RU2810927C2 |
| PHARMACEUTICAL DRUG FORM FOR PERORAL INTRODUCTION TO REDUCE INTER-INDIVIDUAL VARIABILITY, IN PARACETAMOL-CONTAINING COMPOSITIONS IN PATIENT |
2009 |
- Klark Dzheffri D'Juk Ehdvard
- Grehttehn Timoti Dzhejms
- Bernett Ian
|
RU2517139C2 |
| HIGH DOSAGE STRENGTH TABLETS OF RUCAPARIB |
2015 |
|
RU2705156C2 |
